Abstract: This invention relates to the expansion of primary cholangiocytes in the form of cholangiocyte organoids (COs) using culture conditions in which canonical Wnt signalling is inhibited and non-canonical Wnt/PCP signalling is potentiated. Methods of expanding primary cholangiocytes, expanded populations of cholangiocytes and medical applications of expanded cholangiocytes are provided.
| # | Name | Date |
|---|---|---|
| 1 | 202017001786-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [13-01-2020(online)].pdf | 2020-01-13 |
| 2 | 202017001786-STATEMENT OF UNDERTAKING (FORM 3) [13-01-2020(online)].pdf | 2020-01-13 |
| 3 | 202017001786-FORM 1 [13-01-2020(online)].pdf | 2020-01-13 |
| 4 | 202017001786-DRAWINGS [13-01-2020(online)].pdf | 2020-01-13 |
| 5 | 202017001786-DECLARATION OF INVENTORSHIP (FORM 5) [13-01-2020(online)].pdf | 2020-01-13 |
| 6 | 202017001786-COMPLETE SPECIFICATION [13-01-2020(online)].pdf | 2020-01-13 |
| 7 | 202017001786.pdf | 2020-01-15 |
| 8 | 202017001786-FORM 3 [12-02-2020(online)].pdf | 2020-02-12 |
| 9 | 202017001786-FORM-26 [17-02-2020(online)].pdf | 2020-02-17 |
| 10 | 202017001786-Proof of Right [05-06-2020(online)].pdf | 2020-06-05 |
| 11 | 202017001786-RELEVANT DOCUMENTS [13-10-2020(online)].pdf | 2020-10-13 |
| 12 | 202017001786-FORM 13 [13-10-2020(online)].pdf | 2020-10-13 |
| 13 | 202017001786-FORM 18 [04-06-2021(online)].pdf | 2021-06-04 |
| 14 | 202017001786-Power of Attorney-200220.pdf | 2021-10-19 |
| 15 | 202017001786-Correspondence-200220.pdf | 2021-10-19 |
| 16 | 202017001786-FORM 3 [30-10-2023(online)].pdf | 2023-10-30 |